A novel mutation in phospholamban causes a mixed hypertrophic and dilated cardiomyopathy phenotype with autosomal dominant inheritance

A novel mutation in phospholamban causes a mixed hypertrophic and dilated cardiomyopathy phenotype with autosomal dominant inheritance

Bibliographic Details
Main Authors:	Carballo, S, Blair, E, Watkins, H
Format:	Conference item
Published:	2004

Similar Items

Autosomal dominant familial dilated cardiomyopathy caused by a novel mutation in phospholamban
by: Carballo, S, et al.
Published: (2004)

Autosomal dominant HCM and DCM phenotype caused by a novel mutation in phospholamban
by: Carballo, S, et al.
Published: (2004)

Early onset malignant hypertrophic cardiomyopathy caused by mutations in MYBPC3
by: Carballo, S, et al.
Published: (2003)

Identification and functional analysis of cardiac troponin I as a novel disease gene in autosomal dominant familial dilated cardiomyopathy
by: Carballo, S, et al.
Published: (2006)

Novel mutations in cardiac MYBPC3 causing early onset malignant hypertrophic cardiomyopathy
by: Carballo, S, et al.
Published: (2005)

A rare cause of mixed hypertrophic and dilated phenotype cardiomyopathy – the MELAS syndrome
by: Casian Mihnea, et al.
Published: (2023-09-01)

Novel mutations in cardiac MYPBC3 cause early onset malignant hypertrophic cardiomyopathy (HCM)
by: Carballo, S, et al.
Published: (2005)

Comparison of the functional effects of mutations in troponin T which cause dilated and hypertrophic cardiomyopathies
by: Robinson, P, et al.
Published: (2002)

Identification and functional characterization of cardiac troponin I as a novel disease gene in autosomal dominant dilated cardiomyopathy.
by: Carballo, S, et al.
Published: (2009)

Novel mutations in cardiac MYBPC3 and early onset malignant hypertrophic cardiomyopathy
by: Carballo, S, et al.
Published: (2005)

Mutations in cis can confound genotype-phenotype correlations in hypertrophic cardiomyopathy.
by: Blair, E, et al.
Published: (2001)

Double mutations in CIS can confound genotype-phenotype correlations in hypertrophic cardiomyopathy
by: Blair, E, et al.
Published: (2000)

Structures of PKA–phospholamban complexes reveal a mechanism of familial dilated cardiomyopathy
by: Juan Qin, et al.
Published: (2022-03-01)

Genetic clues to disease pathways in hypertrophic and dilated cardiomyopathies.
by: Watkins, H
Published: (2003)

Ascertainment strategies and genotype:phenotype correlations in hypertrophic cardiomyopathy.
by: Blair, E, et al.
Published: (2003)

A novel heterozygous missense MYH7 mutation potentially causes an autosomal dominant form of myosin storage myopathy with dilated cardiomyopathy
by: Niloofar Naderi, et al.
Published: (2023-10-01)

Investigation of troponin I mutations causing familial hypertrophic cardiomyopathy
by: Abdulrazzak, H, et al.
Published: (2001)

Cardiac Steatosis Detected in Hypertrophic Cardiomyopathy, Dilated Cardiomyopathy and Aortic Stenosis
by: Suttie, J, et al.
Published: (2011)

Obesity-related ventricular remodelling is exacerbated in dilated and hypertrophic cardiomyopathy
by: Rayner, JJ, et al.
Published: (2020)

Familial dilated cardiomyopathy caused by an alpha-tropomyosin mutation: the distinctive natural history of sarcomeric dilated cardiomyopathy.
by: Lakdawala, N, et al.
Published: (2010)

MicroRNAs in Hypertrophic, Arrhythmogenic and Dilated Cardiomyopathy
by: Enrica Chiti, et al.
Published: (2021-09-01)

Hypertrophic, Dilated, and Arrhythmogenic Cardiomyopathy: Where Are We?
by: Hamza El Hadi, et al.
Published: (2023-02-01)

Precision and genomic medicine for dilated and hypertrophic cardiomyopathy
by: Seitaro Nomura, et al.
Published: (2023-03-01)

Functional effects of mutations in troponin T and tropomyosin which cause dilated cardiomyopathy
by: Robinson, P, et al.
Published: (2003)

Hypertrophic cardiomyopathy in Noonan Syndrome closely mimics familial hypertrophic cardiomyopathy due to sarcomeric mutations.
by: Hudsmith, L, et al.
Published: (2006)

Dilated cardiomyopathy and the desmin gene.
by: Mayosi, B, et al.
Published: (2000)

Evidence from human myectomy samples that MYBPC3 mutations cause hypertrophic cardiomyopathy through haploinsufficiency.
by: Marston, S, et al.
Published: (2009)

Dilated and hypertrophic cardiomyopathy mutations in troponin and alpha-tropomyosin have opposing effects on the calcium affinity of cardiac thin filaments.
by: Robinson, P, et al.
Published: (2007)

Direct evidence in man for haploinsufficiency as the mechanism of action of myosin-binding protein C mutations that cause hypertrophic cardiomyopathy
by: Carballo, S, et al.
Published: (2008)

Genomic Context Differs Between Human Dilated Cardiomyopathy and Hypertrophic Cardiomyopathy
by: Megan J. Puckelwartz, et al.
Published: (2021-04-01)

Is Hypertrophic Cardiomyopathy Always a Familial and Inherited Disease?
by: Jiri Bonaventura, et al.
Published: (2023-06-01)

Effects of myosin variants on interacting-heads motif explain distinct hypertrophic and dilated cardiomyopathy phenotypes
by: Lorenzo Alamo, et al.
Published: (2017-06-01)

Digenic Inheritance of LAMA4 and MYH7 Mutations in Patient with Infantile Dilated Cardiomyopathy
by: Atiyeh M Abdallah, et al.
Published: (2019-01-01)

Desmoplakin mutation underlying autosomal dominant arrhythmogenic cardiomyopathy, palmoplantar keratoderma, and curly hair
by: Colin Kincaid, BS, et al.
Published: (2023-06-01)

How do MYBPC3 mutations cause hypertrophic cardiomyopathy?
by: Marston, S, et al.
Published: (2012)

Beyond the sarcomere: CSRP3 mutations cause hypertrophic cardiomyopathy.
by: Geier, C, et al.
Published: (2008)

Structure-function relationships of eight mutations in troponin and tropomyosin that cause dilated cardiomyopathy
by: Mirza, M, et al.
Published: (2004)

Linked genetic modifiers in hypertrophic cardiomyopathy
by: Ektisham, J, et al.
Published: (2004)

Functional analysis of hypertrophic cardiomyopathy missense mutations in the light meromyosin region of beta myosin heavy chain
by: Redwood, C, et al.
Published: (2003)

Further Evidence of Autosomal Recessive Inheritance of <i>RPL3L</i> Pathogenic Variants with Rapidly Progressive Neonatal Dilated Cardiomyopathy
by: Hemanth Nannapaneni, et al.
Published: (2022-02-01)